Clinical Trial Update: Impact of Sunitinib Bioavailability on Toxicity and Treatment Efficacy in Patients Treated for Metastatic Renal Cancer

View source ↗

Summary

A terminated clinical trial assessed whether differences in sunitinib bioavailability influence treatment toxicity and efficacy in patients with metastatic rena…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Metastatic Kidney Cancer | Status: TERMINATED